Crossref Citations
This Book has been
cited by the following publications. This list is generated based on data provided by Crossref.
Heal, Geoffrey
2005.
Corporate Social Responsibility: An Economic and Financial Framework.
The Geneva Papers on Risk and Insurance - Issues and Practice,
Vol. 30,
Issue. 3,
p.
387.
Bright, David
2006.
Virtuousness Is Necessary for Genuineness in Corporate Philanthropy.
Academy of Management Review,
Vol. 31,
Issue. 3,
p.
752.
Galambos, Louis
2006.
Knowledge Accumulation and Industry Evolution.
p.
145.
Lofstedt, Ragnar E.
2007.
The Impact of the Cox-2 Inhibitor Issue on Perceptions of the Pharmaceutical Industry: Content Analysis and Communication Implications.
Journal of Health Communication,
Vol. 12,
Issue. 5,
p.
471.
Yi, Doogab
2008.
Cancer, Viruses, and Mass Migration: Paul Berg’s Venture into Eukaryotic Biology and the Advent of Recombinant DNA Research and Technology, 1967–1980.
Journal of the History of Biology,
Vol. 41,
Issue. 4,
p.
589.
Daemmrich, Arthur
2009.
Synthesis by microbes or chemists? Pharmaceutical research and manufacturing in the antibiotic era.
History and Technology,
Vol. 25,
Issue. 3,
p.
237.
Goldstein, Jeffrey
Hazy, James K.
and
Lichtenstein, Benyamin B.
2010.
Complexity and the Nexus of Leadership.
p.
125.
Chen, Connie E.
Gilliland, C. Taylor
Purcell, Jay
Kishore, Sandeep P.
and
Lustigman, Sara
2010.
The Silent Epidemic of Exclusive University Licensing Policies on Compounds for Neglected Diseases and Beyond.
PLoS Neglected Tropical Diseases,
Vol. 4,
Issue. 3,
p.
e570.
Goldstein, Jeffrey
Hazy, James K.
and
Lichtenstein, Benyamin B.
2010.
Complexity and the Nexus of Leadership.
p.
19.
2010.
スタチン発見の検証(日本で発見された薬剤).
Journal of JCS Cardiologists,
Vol. 18,
Issue. 2,
p.
362.
ENDO, Akira
2010.
KAGAKU TO SEIBUTSU,
Vol. 48,
Issue. 4,
p.
276.
Conrad, Charles
Baker, Jane Stuart
Cudahy, Chris
and
Willyard, Jennifer
2010.
The Handbook of Crisis Communication.
p.
607.
ENDO, Akira
2010.
A historical perspective on the discovery of statins.
Proceedings of the Japan Academy, Series B,
Vol. 86,
Issue. 5,
p.
484.
CORLEY, T. A. B.
and
GODLEY, ANDREW
2011.
The veterinary medicine industry in Britain in the twentieth century1.
The Economic History Review,
Vol. 64,
Issue. 3,
p.
832.
John, Richard R.
2011.
Business Historians and the Challenge of Innovation.
Business History Review,
Vol. 85,
Issue. 1,
p.
185.
Chakraborty, Sweta
and
Lofstedt, Ragnar
2012.
Transparency Initiative by the FDA’s Center for Drug Evaluation and Research (CDER): Two qualitative studies of Public Perceptions.
European Journal of Risk Regulation,
Vol. 3,
Issue. 1,
p.
57.
Li, Jie Jack
2013.
Drug Discovery.
p.
1.
Kobrak, Christopher
2013.
The Concept of Reputation in Business History.
Business History Review,
Vol. 87,
Issue. 4,
p.
763.
Bisacchi, Gregory S.
and
Manchester, John I.
2015.
A New-Class Antibacterial—Almost. Lessons in Drug Discovery and Development: A Critical Analysis of More than 50 Years of Effort toward ATPase Inhibitors of DNA Gyrase and Topoisomerase IV.
ACS Infectious Diseases,
Vol. 1,
Issue. 1,
p.
4.
Lazonick, William
Hopkins, Matt
Jacobson, Ken
Sakinc, Mustafa Erdem
and
Tulum, Oner
2017.
US Pharma's Financialized Business Model.
SSRN Electronic Journal ,